News for Healthier Living

Biomarkers Predict Patients with Glioblastoma Who Will Survive Longer After Treatment with Cancer-Targeting Virus

* Glioblastoma is a deadly brain cancer that suppresses the immune system and doesn't respond well to available therapies * Researchers engineered a cancer-targeting virus that can be injected directly in glioblastoma tumors * Adding an immune booster to the virus increased the length of survival in a subset of patients and helped identify blood biomarkers in patients most likely to benefit

February 11, 2026


February 11 2026

February 10 2026

February 9 2026

February 8 2026

February 7 2026

February 6 2026

February 5 2026

February 4 2026

February 3 2026

February 2 2026

February 1 2026

January 31 2026

January 30 2026

January 29 2026

January 28 2026